Volume 3, Issue 2 (2017)
From the Editors
From the Editor: Context creates meaning for evidence
James Peter Meza
Compared to maximal current management standards, oscillating positive expiratory pressure devices have not been shown to improve clinically relevant outcomes in COPD patients with acute exacerbation
Daniel P. Noack and Gaybriel Newton
Clopidogrel alone is safer than clopidogrel and aspirin for secondary prevention of acute ischemic stroke.
Bradford J. Woelke, Daniel Angell DO, and Katherine Litow MD
Hydroxyurea lowers the frequency of sickle cell vaso-occlusive crises
Corey S. Macrander
Remote video monitoring is another example of “dying on the machine” for critically ill patients
Noveera A. Mirza, Joshua A. Christian, and Christopher M. LaJeunesse
Reframing outcome measures for thrombolytics in acute ischemic stroke
Brandon Baker, Charles W. Kropf, Nicholus Yee, and James Peter Meza
Letters to the Editor
Treating diabetic ketoacidosis with subcutaneous insulin?
Marlene Aziza Azar
- Editor in Chief
- James P. Meza M.D., Ph.D
- Managing Editor
- Nicholus Yee, M.D.
- Associate Editors
- Bernard Ewigman, M.D. MSPH FAAFP
- Anne Victoria Neale, Ph.D., MPH
- Kendra Schwartz, M.D., MSPH
- Allen F. Shaughnessy, Pharm.D., M.Med.Ed.
- Editorial Board
- Robert Bryce, D.O.
- J. Timothy Caldwell, M.D., Ph.D.
- John Dawdy, M.D., MHS
- Mark D. Faber, M.D. MACM
- Scott Kaatz, D.O., M.Sc., FACP, SFHM
- Diane Levine, M.D., FACP
- Daniel Passerman, D.O.
- Anthony M. Provenzano, M.D.
- Senior Student Editors
- Thomas C. Bolig, B.S., M.S.
- Blake Arthurs, B.S.
- Natalie Wiseman, B.S.